tradmap

DGX Quest Diagnostics

$194.97 -1.44%

S&P 500 Companies

Held by SPYVOOIVV

Healthcare · Services-Medical Laboratories

Quest Diagnostics (DGX) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $21.6 billion. Shares last traded at $194.97, 8.6% below their 52-week high. Over the past year the stock is up 8.9%. DGX trades at a price-to-earnings ratio of 21.76, below the Services-Medical Laboratories median of 23.93. Net profit margin is 9.0%, above the peer median of -8.0%. Revenue grew 11.8% year over year. The shares yield 1.7% in dividends.

Market Cap
$21.6B
Shares Out
110.7M
EPS (TTM)
$15.16
P/E Ratio
12.86
P/S Ratio
1.96
P/B Ratio
2.93
Dividend / Share
$3.26
Dividend Yield
1.67%
52-Week High
$213.40
52-Week Low
$164.66
Volume
44,622
Avg Vol (3m)
44,172.524

Performance

1W
-4.36%
1M
+2.35%
3M
+0.42%
6M
+9.17%
YTD
+12.23%
1Y
+8.94%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
45.96
SMA (50)
$194.89
SMA (200)
$189.59
Price vs SMA50
+0.04%
Price vs SMA200
+2.84%
ATR (14)
$4.42

Financials

Revenue
$11.0B
Net Income
$992M
Gross Margin
32.9%
Operating Margin
14.1%
Net Margin
9.0%
Return on Equity
13.5%
Return on Assets
5.9%
Current Ratio
1.18
Debt / Equity
0.77
Revenue Growth (YoY)
+11.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $2.24 2026-04-22
FY 2025 $8.75 2026-02-26
Q3 2025 $6.57 2025-10-21
Q2 2025 $4.41 2025-07-23
Q1 2026 $1.94 2026-04-22
FY 2025 $7.69 2026-02-26

Full earnings history →

Services-Medical Laboratories peers

DGX vs 14 industry peers (Services-Medical Laboratories), by market cap.

P/E vs peers
21.76 / 23.93 med
-9% discount
P/S vs peers
1.96 / 1.94 med
+1% premium
Net margin vs peers
9.0% / -8.0% med
above median
1–14 of 14
NTRANatera, Inc.$33.1B-159.2314.37-9.0%+2.17%
DGXQuest Diagnostics$21.6B21.761.969.0%-1.44%
LHLabcorp$21.0B23.931.506.3%-1.40%
GHGuardant Health, Inc.$17.5B-41.9817.80-42.4%+2.06%
CAICaris Life Sciences, Inc.$5.2B+3.41%
BLLNBilliontoone, Inc.$4.8B+5.38%
VCYTVeracyte, Inc.$4.3B64.478.2812.8%+4.50%
CELCCelcuity Inc.$4.3B-24.15-0.45%
RDNTRadnet, Inc.$4.2B-226.562.07-0.9%+1.83%
GRALGrail, Inc.$2.7B+7.35%
FTREFortrea Holdings Inc.$1.4B-0.20%
CDNACaredx, Inc.$1.4B-63.383.56-5.6%+11.89%
PSNLPersonalis, Inc.$1.1B-13.55+8.29%
LMRILumexa Imaging Holdings, Inc.$907M+7.76%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.